MEINI, GENNY
 Distribuzione geografica
Continente #
NA - Nord America 1.731
EU - Europa 1.345
AS - Asia 193
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
SA - Sud America 1
Totale 3.274
Nazione #
US - Stati Uniti d'America 1.728
GB - Regno Unito 443
IT - Italia 223
IE - Irlanda 219
SE - Svezia 147
CN - Cina 146
UA - Ucraina 132
FR - Francia 62
DE - Germania 45
FI - Finlandia 32
VN - Vietnam 27
ES - Italia 23
BE - Belgio 11
IN - India 9
CA - Canada 3
TR - Turchia 3
BJ - Benin 2
JP - Giappone 2
RU - Federazione Russa 2
A1 - Anonimo 1
AL - Albania 1
AU - Australia 1
BG - Bulgaria 1
BY - Bielorussia 1
EC - Ecuador 1
EE - Estonia 1
HK - Hong Kong 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
NL - Olanda 1
PH - Filippine 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 3.274
Città #
Southend 407
Fairfield 293
Dublin 218
Chandler 195
Ashburn 144
Seattle 125
Woodbridge 122
Jacksonville 109
Cambridge 103
Wilmington 101
Ann Arbor 100
Siena 96
Houston 89
Nanjing 37
Beijing 34
Princeton 34
Dong Ket 27
Menlo Park 24
Bologna 23
Málaga 23
Boardman 19
San Diego 15
Nanchang 14
San Mateo 13
Helsinki 12
Brussels 11
Milan 10
Shanghai 10
New York 8
Changsha 7
Tianjin 7
Hebei 6
Jiaxing 6
Norwalk 6
Phoenix 6
Shenyang 5
Düsseldorf 4
Falls Church 4
Florence 4
Ningbo 4
Rome 4
San Francisco 4
Atlanta 3
Bangalore 3
Hangzhou 3
Izmir 3
Jinan 3
Kunming 3
Lancaster 3
Mestre 3
Venezia 3
Centro 2
Cotonou 2
Fremont 2
Guangzhou 2
Guido 2
Marano Vicentino 2
Narcao 2
Tappahannock 2
Torino 2
Toronto 2
Zhengzhou 2
Almaty 1
Bagno A Ripoli 1
Bolton 1
Canberra 1
Central 1
Chicago 1
Chiswick 1
Colombo 1
Edinburgh 1
Elbasan 1
Falkenstein 1
Fontana 1
Giessen 1
Groningen 1
Guayaquil 1
Incisa 1
Kilburn 1
Latina 1
Livorno 1
London 1
Los Angeles 1
Luxembourg 1
Manila 1
Mcallen 1
Miami Beach 1
Minsk 1
Modena 1
Montreal 1
Oklahoma City 1
Reggio Nell'emilia 1
Saint Petersburg 1
Simi Valley 1
Southwark 1
Stockholm 1
Taizhou 1
Tallinn 1
Tashkent 1
Verona 1
Totale 2.570
Nome #
A Prognostic Model for Estimating the Time to Virologic Failure in HIV-1 Infected Patients Undergoing a New Combination Antiretroviral Therapy Regimen 330
Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study group 176
Total cellular HIV-1 DNA decreases after switching to raltegravir-based regimens in patients with suppressed HIV-1 RNA 175
Stability of unfrozen whole blood DNA for remote genotypic analysis of HIV-1 coreceptor tropism 164
Switch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy: 48-Week results of a randomized trial 162
Changing patterns in HIV-1 non-B clade prevalence and diversity in Italy over three decades 155
Comparative determination of HIV-1 coreceptor tropism by Enhanced Sensitivity Trofile, gp120 V3-loop RNA and DNA genotyping 150
Low-cost simultaneous detection of CCR5-delta32 and HLA-B*5701 alleles in human immunodeficiency virus type 1 infected patients by selective multiplex endpoint PCR 147
Development of an internally controlled quantitative PCR to measure total cell-associated HIV-1 DNA in blood 144
Switch to raltegravir-based regimens and HIV DNA decrease in patients with suppressed HIV RNA 142
Low rate of virological failure and maintenance of susceptibility to HIV-1 protease inhibitors with first-line lopinavir/ritonavir-based antiretroviral treatment in clinical practice 140
Prevalence of HIV-1 integrase mutations related to resistance to dolutegravir in raltegravir naïve and pretreated patients. 137
Longitudinal analysis of HIV-1 coreceptor tropism by single and triplicate HIV-1 RNA and DNA sequencing in patients undergoing successful first-line antiretroviral therapy 137
Near Full-Length Sequence Analysis of HIV Type 1 BF Recombinants from Italy. 135
Drug resistance testing through remote genotyping and predicted treatment options in human immunodeficiency virus type 1 infected Tanzanian subjects failing first or second line antiretroviral therapy 132
Rilpivirine resistance and the dangerous liaisons with substitutions at position 184 among patients infected with HIV-1: analysis from a national drug-resistance database (ARCA) 124
First external quality assurance program of the Italian HLA-B*57:01 Network assessing the performance of clinical virology laboratories in HLA-B*57:01 testing 123
null 121
Naturally occurring hepatitis C virus (HCV) NS3/4A protease inhibitor resistance-related mutations in HCV genotype 1-infected subjects in Italy. 109
null 108
Impact of remote vs. local sampling on sensitivity of genotypic antiretroviral resistance testing 87
Performance of genotypic tropism testing on proviral DNA in clinical practice: results from the DIVA study group. 81
Analysis of genetic and viral determinants of HBsAg levels in patients with chronic HBV infection 78
Dysfunctional phenotypes of CD4+ and CD8+ T cells are comparable in patients initiating ART during early or chronic HIV-1 infection 36
Frequent Detection of Antiretroviral Drug Resistance in HIV-1-Infected Orphaned Children Followed at a Donor-Funded Rural Pediatric Clinic in Dodoma, Tanzania 35
Totale 3.328
Categoria #
all - tutte 9.079
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.079


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019244 0 0 0 0 0 0 0 0 0 0 126 118
2019/2020733 92 36 61 118 47 53 57 87 82 49 12 39
2020/2021480 17 66 17 41 24 54 30 68 40 32 34 57
2021/2022313 22 40 15 51 15 11 18 16 13 31 23 58
2022/2023534 23 62 53 94 52 95 14 43 49 27 16 6
2023/2024283 14 7 19 24 3 73 125 10 0 6 2 0
Totale 3.328